Disrupted Nighttime Sleep (DNS) in Pediatric Narcolepsy

小儿发作性睡病的夜间睡眠 (DNS) 中断

• 批准号: 10401835
• 负责人: Kiran Prasad Maski
• 金额: $ 17.68万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-01 至 2024-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10401835
• 关键词: Adolescence; Affect; Age; Behavior; Behavioral; Behavioral Sciences; Boston; Cataplexy; Child; Childhood; Chronic Disease; Clinical Trials; Cognition; Cognitive; Complement; Cross-Sectional Studies; Data; Development; Disease; Drowsiness; Emotional; Emotions; Environment; Evolution; Foundations; Frequencies; Goals; Guidelines; Hyperactivity; Impairment; Incidence; Intuition; Knowledge; Light; Link; Measures; Medicine; Memory; Mentors; Mentorship; Methods; Mood Disorders; Moods; Narcolepsy; Nerve Degeneration; Neurology; Neurons; Neurosciences; Outcome; Pathologic; Pathology; Patients; Pediatric Hospitals; Pediatric Neurology; Pediatric cohort; Pharmaceutical Preparations; Physicians; Physiology; Play; Problem Solving; Process; Prospective Studies; Protocols documentation; Public Health; Public Health Schools; REM Sleep; Rare Diseases; Research; Research Design; Research Methodology; Research Support; Role; Scientist; Sleep; Sleep Architecture; Sleep Disorders; Sleep Fragmentations; Sleep Stages; Sleep disturbances; Sodium Oxybate; Stage III Sleep; Symptoms; Techniques; Technology; Testing; Time; Training; age group; aged; analytical method; base; burden of illness; cognitive neuroscience; cohort; comorbidity; diagnostic biomarker; disorder control; emotion regulation; emotional functioning; experimental study; hypocretin; improved; indexing; innovation; mathematical model; medical schools; memory consolidation; memory process; multidisciplinary; negative affect; nervous system disorder; neurophysiology; non rapid eye movement; novel; pediatric patients; predictive marker; psychologic; skills; statistics; treatment strategy

ABSTRACT The proposal will support the research and further Dr. Kiran Maski's training as a physician-scientist in sleep neurology. Dr. Maski's long-term objectives are to examine the neurophysiology of nocturnal sleep in pediatric narcolepsy and its relationship to cognitive and psychological co-morbidities common to this disease, to identify potential sleep neurophysiological diagnostic and predictive biomarkers, and develop and test sleep- specific treatments to reduce disease burden of pediatric narcolepsy patients. To achieve these goals, a training plan focused on (1) analytic skills to study sleep dynamics, (2) fundamental knowledge in cognitive and behavioral neuroscience and sleep-wake physiology, (3) longitudinal and clinical trial research design to facilitate rare disease research is proposed to complement Dr. Maski's background in child neurology and sleep medicine. This training will be accomplished through formal coursework, hands on training, and multi- disciplinary mentorship with world-renown experts in sleep-wake neurophysiology (Dr. Thomas Scammell) and cognitive neuroscience (Dr. Robert Stickgold). Additional consultants and collaborators with expertise in mathematical modeling, statistics, behavioral science, and research methodology utilizing remote audiovisual technology will enrich Dr. Maski's training and proposed research. This training will occur in the context of the rich scholarly environment of Harvard Medical School, Harvard T.H. Chan School of Public Health and Boston Children's Hospital. The research plan is devised to test the central hypothesis that disrupted nighttime sleep (DNS) in pediatric narcolepsy type 1 (NT1) is a specific and dynamic form of sleep pathology that impairs normal emotional and memory processes that occur during sleep. To test this hypothesis, we propose three complimentary but independent aims. In Aim 1, we conduct a cross-sectional study to define DNS with measures unique to pediatric NT1 compared to other sleep disorders and controls. In Aim 2, we study changes in DNS using translational analytic methods within a pediatric NT1 cohort. Lastly, in Aim 3, we investigate predicted changes to sleep architecture between drug-free pediatric NT1 patients, pediatric NT1 patients on established sodium oxybate therapy (a sedating drug that treats DNS) and healthy, aged-matched controls to determine direct effects of sleep fragmentation on memory consolidation and post-sleep emotional processes. Public Health: Substantial evidence links sleep with cognitive and emotional processes. Yet , little is known of the specific pathologic sleep changes that occur in pediatric neurologic diseases and the role this pathology plays in the development of burdensome cognitive and psychological co-morbidities. This proposal serves to provide new analytic methods to characterize sleep pathology in neurological diseases like narcolepsy, test novel methods that show direct cognitive and psychological effects of sleep disruption, and forms the foundation for sleep-specific treatment strategies to reduce disease burden in neurological diseases.

抽象的 该提案将支持该研究并进一步支持 Kiran Maski 博士作为一名医师科学家的培训 睡眠神经病学。马斯基博士的长期目标是研究夜间睡眠的神经生理学 小儿发作性睡病及其与该疾病常见的认知和心理合并症的关系， 识别潜在的睡眠神经生理学诊断和预测生物标志物，并开发和测试睡眠 减轻儿科发作性睡病患者疾病负担的具体治疗方法。为了实现这些目标， 培训计划侧重于 (1) 研究睡眠动态的分析技能，(2) 认知和睡眠方面的基础知识 行为神经科学和睡眠觉醒生理学，（3）纵向和临床试验研究设计 建议促进罕见疾病研究，以补充 Maski 博士在儿童神经病学方面的背景，以及 安眠药。该培训将通过正式课程、实践培训和多种形式来完成 世界知名睡眠-觉醒神经生理学专家（Thomas Scammell 博士）的学科指导 认知神经科学（罗伯特·斯蒂克戈尔德博士）。具有以下专业知识的其他顾问和合作者 利用远程视听的数学建模、统计学、行为科学和研究方法 技术将丰富 Maski 博士的培训和拟议研究。本次培训将在 哈佛医学院丰富的学术环境、Harvard T.H.波士顿陈公共卫生学院 儿童医院。该研究计划旨在测试扰乱夜间睡眠的中心假设 1 型小儿发作性睡病 (NT1) 中的 DNS（DNS）是一种特定的、动态的睡眠病理学形式，会损害 睡眠期间发生的正常情绪和记忆过程。为了检验这个假设，我们提出了三个 互补但独立的目标。在目标 1 中，我们进行了一项横断面研究来定义 DNS 与其他睡眠障碍和对照相比，儿科 NT1 独有的测量方法。在目标 2 中，我们研究变化 在儿科 NT1 队列中使用翻译分析方法进行 DNS 研究。最后，在目标 3 中，我们调查 预测未用药儿科 NT1 患者与接受药物治疗的儿科 NT1 患者之间睡眠结构的变化 建立了羟丁酸钠疗法（一种治疗 DNS 的镇静药物）和健康、年龄匹配的对照，以 确定睡眠碎片对记忆巩固和睡后情绪过程的直接影响。 公共卫生：大量证据表明睡眠与认知和情绪过程有关。然而，人们却知之甚少 儿科神经系统疾病中发生的特定病理性睡眠变化及其病理学的作用 在造成繁重的认知和心理并发症的过程中发挥作用。该提案旨在 提供新的分析方法来表征神经系统疾病（如发作性睡病）的睡眠病理学、测试 显示睡眠中断的直接认知和心理影响的新方法，并形成 为减轻神经系统疾病负担的睡眠特异性治疗策略奠定了基础。

项目成果

How should disrupted nocturnal sleep be characterized in narcolepsy type 1?

1 型发作性睡病的夜间睡眠中断应如何表征？

• DOI: 10.1093/sleep/zsac096
• 发表时间: 2022
• 期刊: Sleep
• 影响因子: 5.6
• 作者: Maski,Kiran;Trotti,LynnMarie
• 通讯作者: Trotti,LynnMarie

Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline.

• DOI: 10.5664/jcsm.9328
• 发表时间: 2021-09-01
• 期刊: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
• 作者: Maski, Kiran;Trotti, Lynn Marie;Watson, Nathaniel F
• 通讯作者: Watson, Nathaniel F

Remote Assessment of Pediatric Patients with Daytime Sleepiness and Healthy Controls: A Pilot Study of Feasibility and Reliability.

• DOI: 10.1177/2329048x211048064
• 发表时间: 2021-01
• 期刊: Child neurology open
• 作者: Worhach J;Boduch M;Zhang B;Maski K
• 通讯作者: Maski K

Development and Validation of the Pediatric Hypersomnolence Survey.

儿科嗜睡症调查的开发和验证。

• DOI: 10.1212/wnl.0000000000200187
• 发表时间: 2022
• 期刊: Neurology
• 影响因子: 9.9
• 作者: Maski,Kiran;Worhach,Jennifer;Steinhart,Erin;Boduch,Madeline;Morse,AnneMarie;Strunc,Michael;Scammell,Thomas;Owens,Judith;Jesteadt,Lindsay;Crisp,Claire;Williams,David;Sideridis,Georgios
• 通讯作者: Sideridis,Georgios